Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Sees Large Increase in Short Interest

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRFGet Free Report) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 84,500 shares, a growth of 32.2% from the May 31st total of 63,900 shares. Based on an average daily trading volume, of 1,600 shares, the short-interest ratio is currently 52.8 days.

Surgical Science Sweden AB (publ) Price Performance

SUSRF stock remained flat at $11.85 during midday trading on Monday. The stock has a fifty day moving average of $13.72 and a two-hundred day moving average of $13.06. Surgical Science Sweden AB has a 12 month low of $11.85 and a 12 month high of $14.30.

Surgical Science Sweden AB (publ) Company Profile

(Get Free Report)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.

Read More

Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.